Mirum Pharmaceuticals Inc
NASDAQ:MIRM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
23.57
46.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mirum Pharmaceuticals Inc
Wall Street
Price Targets
MIRM Price Targets Summary
Mirum Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
MIRM
is 63.8 USD
with a low forecast of 50.5 USD and a high forecast of 76.65 USD.
MIRM Last Price Targets
Mirum Pharmaceuticals Inc
The latest public price target was made on Nov 12, 2024 by
Dae Gon Ha
from
Stifel Nicolaus
,
who expects
MIRM
stock to
rise by 69%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Dae Gon Ha
Stifel Nicolaus
|
70
USD
Upside 69% |
1 month ago
Nov 12, 2024
|
Mirum Pharamceuticals (MIRM) PT Raised to $70 at Stifel
StreetInsider
|
Brian Skorney
Robert W. Baird
|
44
USD
Upside 6% |
4 months ago
Aug 8, 2024
|
Mirum Pharmaceuticals price target raised to $44 from $39 at Baird
TheFly
|
|
Brian Skorney
Robert W. Baird
|
39
USD
Downside 6% |
6 months ago
Jun 17, 2024
|
Mirum Pharamceuticals (MIRM) PT Raised to $39 at Baird
StreetInsider
|
|
Ed Arce
H.C. Wainwright
|
66
USD
Upside 59% |
6 months ago
Jun 17, 2024
|
Mirum Pharmaceuticals price target raised to $66 from $58 at H.C. Wainwright
TheFly
|
Gavin Clark-Gartner
Evercore ISI
|
62
USD
Upside 49% |
6 months ago
Jun 17, 2024
|
Mirum Pharamceuticals (MIRM) PT Raised to $62 at Evercore ISI
StreetInsider
|
Michael E Ulz
Morgan Stanley
|
57
USD
Upside 37% |
6 months ago
Jun 17, 2024
|
Mirum Pharamceuticals (MIRM) PT Raised to $57 at Morgan Stanley
StreetInsider
|
|
Joshua Schimmer
Cantor Fitzgerald
|
45
USD
Upside 8% |
7 months ago
May 23, 2024
|
Mirum Pharmaceuticals price target raised to $45 from $40 at Cantor Fitzgerald
TheFly
|
|
Dae Gon Ha
Stifel Nicolaus
|
48
USD
Upside 16% |
8 months ago
Apr 16, 2024
|
Mirum Pharmaceuticals initiated with a Buy at Stifel
TheFly
|
|
Ed Arce
H.C. Wainwright
|
58
USD
Upside 40% |
9 months ago
Mar 14, 2024
|
Mirum Pharamceuticals (MIRM) PT Raised to $58 at H.C. Wainwright
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MIRM's stock price target?
Price Target
63.8
USD
According to Wall Street analysts, the average 1-year price target for
MIRM
is 63.8 USD
with a low forecast of 50.5 USD and a high forecast of 76.65 USD.
What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
41%
The
compound annual growth rate
of Mirum Pharmaceuticals Inc's revenue for the next 4 years is
41%.
You don't have any saved screeners yet
